99% Savings - Buy Just @1 Rs X
Glimepiride + Metformin + Rosiglitazone is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
Is the use of Glimepiride + Metformin + Rosiglitazone safe for pregnant women?
Pregnant women may get severe side effects after taking Glimepiride + Metformin + Rosiglitazone. If you are pregnant, do not take Glimepiride + Metformin + Rosiglitazone without a doctor's advice.
Is the use of Glimepiride + Metformin + Rosiglitazone safe during breastfeeding?
Glimepiride + Metformin + Rosiglitazone should not be taken without taking your doctor's advice, as it may have severe side effects on breastfeeding women.
What is the effect of Glimepiride + Metformin + Rosiglitazone on the Kidneys?
Information about safety of Glimepiride + Metformin + Rosiglitazone for kidney is not available since scientific research on this topic is yet to be done.
What is the effect of Glimepiride + Metformin + Rosiglitazone on the Liver?
In the absence of any scientific study on the side effects of Glimepiride + Metformin + Rosiglitazone on the liver, information on safety of Glimepiride + Metformin + Rosiglitazone for liver is unavailable.
What is the effect of Glimepiride + Metformin + Rosiglitazone on the Heart?
The heart can be affected by Glimepiride + Metformin + Rosiglitazone. If you experience any unwanted effects of this drug, stop taking it and consult your doctor. You should restart the medicine only after medical advice.
Glimepiride + Metformin + Rosiglitazone should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Glimepiride + Metformin + Rosiglitazone unless your doctor advises you to do so -
Is this Glimepiride + Metformin + Rosiglitazone habit forming or addictive?
Glimepiride + Metformin + Rosiglitazone does not cause addiction.
Is it safe to drive or operate heavy machinery when consuming?
Yes, you can operate a vehicle or heavy machinery after taking Glimepiride + Metformin + Rosiglitazone since it does not cause drowsiness.
Is it safe?
Yes, but consume Glimepiride + Metformin + Rosiglitazone only on doctor's advice.
Is it able to treat mental disorders?
No, the use of Glimepiride + Metformin + Rosiglitazone in mental disorders is not effective.
Interaction between Food and Glimepiride + Metformin + Rosiglitazone
Taking Glimepiride + Metformin + Rosiglitazone with food does not cause any problems.
Interaction between Alcohol and Glimepiride + Metformin + Rosiglitazone
Taking Glimepiride + Metformin + Rosiglitazone with alcohol can have severely harmful effects on your health.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Amaryl (glimepiride)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 272
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1156-1158
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Glucophage® (metformin hydrochloride)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 275-276
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 825-826
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Avandia (rosiglitazone maleate) Tablets
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 276-277